keyword
https://read.qxmd.com/read/38636682/positive-association-between-dehydroepiandrosterone-dhea-and-gene-expression-of-the-gamma-aminobutyric-acid-gaba-a-receptor-%C3%AE-subunit
#21
JOURNAL ARTICLE
Ajna Hamidovic, Soojeong Cho, John Davis
Gamma-aminobutyric acid A (GABA-A) receptors in the cells of the immune system enhance anti-inflammatory responses by regulating cytokine secretion, cytotoxic responses, and cell activation. In the CNS, the formation of GABA-A subunits into a pentameric structure has been extensively studied; however, no such study has been conducted in the immune system. The objective of the present study was to examine associations between the levels of steroid hormones and GABA-A receptor δ subunit expression in the immune system...
April 16, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38636679/clinical-presentation-and-spectrum-of-gluten-symptomatology-in-celiac-disease
#22
JOURNAL ARTICLE
Dawn W Adams, Stephanie Moleski, Jacqueline Jossen, Jason A Tye-Din
Views on the clinical presentation and symptomatology of celiac disease have evolved alongside advances in disease detection and understanding of disease pathogenesis. While historically regarded a pediatric illness characterized by malabsorption, it is now better viewed as an immune illness of gluten-specific T cells with systemic manifestations affecting all ages. Its broad presentation, including frequent extraintestinal manifestations and asymptomatic disease, contributes to suboptimal disease detection...
April 16, 2024: Gastroenterology
https://read.qxmd.com/read/38636133/nir-responsive-copper-nanoliposome-composites-for-cascaded-ferrotherapy-via-ferroptosis-actived-icd-and-ifn-%C3%AE-released
#23
JOURNAL ARTICLE
Junrui Wang, Wenli Zhang, Zhuoyan Xie, Xingyue Wang, Jiangshan Sun, Fei Ran, Weixi Jiang, Yun Liu, Zhigang Wang, Haitao Ran, Dajing Guo
Metallic biomaterials activate tumor ferroptosis by increasing oxidative stress, but their efficacy is severely limited in tumor microenvironment. Although interferon gamma (IFN-γ) can promote tumor ferroptosis sensitivity by inhibiting the antioxidant system and promoting lipid accumulation, this effect limited by the lack of IFN-γ accumulation in tumors. Herein, we report a near-infrared (NIR)-responsive HCuS nanocomposite (HCuS-PE@TSL-tlyp-1) that can stimulate immunogenic cell death (ICD)-mediated IFN-γ secretion through exogenous oxidative stress, thereby achieving cascaded ferrotherapy by mutually reinforcing ferroptosis and systemic immunity...
April 15, 2024: Biomaterials
https://read.qxmd.com/read/38635903/cd58-alterations-govern-antitumor-immune-responses-by-inducing-pd-l1-and-ido-in-diffuse-large-b-cell-lymphoma
#24
JOURNAL ARTICLE
Xiyue Xu, Yidan Zhang, Yaxiao Lu, Xiaoyan Zhang, Cuicui Zhao, Jiesong Wang, Qingpei Guan, Yingfang Feng, Meng Gao, Jingwei Yu, Zheng Song, Xia Liu, Zahra Golchehre, Lanfang Li, Weicheng Ren, Qiang Pan-Hammarström, Huilai Zhang, Xianhuo Wang
Recurrent abnormalities in immune surveillance-related genes affect the progression of diffuse large B-cell lymphoma (DLBCL) and modulate the response to therapeutic interventions. CD58 interacts with the CD2 receptor on T cells and natural killer (NK) cells and is recurrently mutated and deleted in DLBCL, suggesting it may play a role in regulating antitumor immunity. Herein, we comprehensively analyzed the genomic characteristics of CD58 through targeted next-generation sequencing, RNA-sequencing, whole-exome sequencing, and single-cell RNA-sequencing in patients with newly diagnosed DLBCL...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635884/crispr-cas9-screening-identifies-kras-induced-cox-2-as-a-driver-of-immunotherapy-resistance-in-lung-cancer
#25
JOURNAL ARTICLE
Jesse Boumelha, Andrea de Castro, Nourdine Bah, Hongui Cha, Sophie de Carné Trécesson, Sareena Rana, Mona Tomaschko, Panayiotis Anastasiou, Edurne Mugarza, Christopher Moore, Robert Goldstone, Philip East, Kevin Litchfield, Se-Hoon Lee, Miriam Molina-Arcas, Julian Downward
Oncogenic KRAS impairs anti-tumor immune responses. As effective strategies to combine KRAS inhibitors and immunotherapies have so far proven elusive, a better understanding of how oncogenic KRAS drives immune evasion is needed to identify approaches that could sensitize KRAS-mutant lung cancer to immunotherapy. In vivo CRISPR-Cas9 screening in an immunogenic murine lung cancer model identified mechanisms by which oncogenic KRAS promotes immune evasion, most notably via upregulation of immunosuppressive cyclooxygenase-2 (COX-2) in cancer cells...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635321/the-gut-microbe-pair-of-oribacterium-sp-gmb0313-and-ruminococcus-sp-gmb0270-confers-complete-protection-against-sars-cov-2-infection-by-activating-cd8-t-cell-mediated-immunity
#26
JOURNAL ARTICLE
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, Chongkai Zhai, Md Minarul Islam, Hyeon J Kim, Seong-Tshool Hong
Despite the potential protective role of the gut microbiome against COVID-19, specific microbes conferring resistance to COVID-19 have not yet been identified. In this work, we aimed to identify and validate gut microbes at the species level that provide protection against SARS-CoV-2 infection. To identify gut microbes conferring protection against COVID-19, we conducted a fecal microbiota transplantation (FMT) from an individual with no history of COVID-19 infection or immunization into a lethal COVID-19 hamster model...
2024: Gut Microbes
https://read.qxmd.com/read/38633656/analysis-of-cuproptosis-related-genes-in-prognosis-and-immune-infiltration-in-grade-4-diffuse-gliomas
#27
JOURNAL ARTICLE
Hui Liu, Xin Bao, Zhirui Zeng, Wei Liu, Meifang Li
BACKGROUND: Grade 4 diffuse gliomas are highly malignant tumours with poor prognosis. Cuproptosis is a novel form of cell death. Cuproptosis genes are associated with various tumours and affect the prognosis of patients with these tumours. However, the relationship between cuproptosis and grade 4 diffuse gliomas remains unclear. METHODS: Differentially expressed genes associated with cuproptosis in grade 4 diffuse gliomas were identified. Second, the prognostic model was established by univariate and multivariate COX regression analyses, and the genes (p < 0...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38632658/tumor-immune-dysfunction-and-exclusion-subtypes-in-bladder-cancer-and-pan-cancer-a-novel-molecular-subtyping-strategy-and-immunotherapeutic-prediction-model
#28
JOURNAL ARTICLE
Kun Zheng, Youlong Hai, Hongqi Chen, Yukun Zhang, Xiaoyong Hu, Kai Ni
BACKGROUND: Molecular subtyping is expected to enable precise treatment. However, reliable subtyping strategies for clinical application remains defective and controversial. Given the significance of tumor immune dysfunction and exclusion (TIDE), we aimed to develop a novel TIDE-based subtyping strategy to guide personalized immunotherapy in the bladder cancer (BC). METHODS: Transcriptome data of BC was used to evaluate the heterogeneity and the status of TIDE patterns...
April 17, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38632642/spatial-and-single-cell-explorations-uncover-prognostic-significance-and-immunological-functions-of-mitochondrial-calcium-uniporter-in-breast-cancer
#29
JOURNAL ARTICLE
Chia-Jung Li, Yen-Dun Tony Tzeng, Jui-Hu Hsiao, Ling-Ming Tseng, Tzu-Sheng Hsu, Pei-Yi Chu
The mitochondrial calcium uniporter (MCU) is a transmembrane protein facilitating the entry of calcium ions into mitochondria from the cell cytosol. Maintaining calcium balance is crucial for enhancing cellular energy supply and regulating cell death. The interplay of calcium balance through MCU and the sodium-calcium exchanger is known, but its regulation in the breast cancer tumor microenvironment remains elusive. Further investigations are warranted to explore MCU's potential in BRCA clinical pathology, tumor immune microenvironment, and precision oncology...
April 17, 2024: Cancer Cell International
https://read.qxmd.com/read/38631714/efficacy-of-lcmv-based-cancer-immunotherapies-is-unleashed-by-intratumoral-injections-of-polyi-c
#30
JOURNAL ARTICLE
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
BACKGROUND: Lymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and humans. LCMV has been engineered for the development of cancer immunotherapies, currently undergoing evaluation in phase I/II clinical trials. Initial findings have demonstrated safety and an exceptional ability to activate and expand tumor-specific T lymphocytes. Combination strategies to maximize the antitumor effectiveness of LCMV-based immunotherapies are being explored...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631235/the-predictive-value-of-conventional-magnetic-resonance-imaging-combined-with-intravoxel-incoherent-motion-parameters-for-evaluating-maternal-and-neonatal-clinical-outcomes-in-patients-with-placenta-accreta-spectrum-disorders
#31
JOURNAL ARTICLE
Jin Zhang, Lingnan Kong, Feifei Qu, Ting Chen, Xin Zhou, Zhiping Ge, Bai Jin, Xuan Zhang, Meng Zhao
INTRODUCTION: We aimed to identify factors predictive of adverse maternal and neonatal outcomes in patients with placenta accreta spectrum (PAS) disorders using magnetic resonance imaging (MRI) and intravoxel incoherent motion (IVIM) parameters. METHOD: Fifty-six normal singleton pregnancies at 33-39 weeks of gestation underwent MRI examination at 1.5 T. The IVIM parameters were obtained from the placenta. The correlation between the f value and postpartum hemorrhage (PPH) and between the f value and transfused units of red blood cells (RBCs) was estimated by linear regression...
April 14, 2024: Placenta
https://read.qxmd.com/read/38630555/overcoming-osimertinib-resistance-with-akt-inhibition-in-egfrm-driven-non-small-cell-lung-cancer-with-pik3ca-pten-alterations
#32
JOURNAL ARTICLE
Ursula Grazini, Aleksandra Markovets, Lucy Ireland, Daniel O'Neill, Benjamin Phillips, Man Xu, Matthias Pfeifer, Tereza Vaclova, Matthew J Martin, Ludovic Bigot, Luc Friboulet, Ryan Hartmaier, Maria Emanuela Cuomo, Simon T Barry, Paul D Smith, Nicolas Floc'h
PURPOSE: Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) indicated for the treatment of EGFR mutated (EGFRm)-driven lung adenocarcinomas. Osimertinib significantly improves progression-free survival in first-line treated patients with EGFRm advanced NSCLC. Despite the durable disease control, the majority of patients receiving osimertinib eventually develop disease progression. EXPERIMENTAL DESIGN: ctDNA profiling analysis on-progression plasma samples from patients treated with osimertinib in both first (Phase 3, FLAURA trial) and second-line trials (Phase 3, AURA3 trial) revealed a high prevalence of PIK3CA/AKT/PTEN alterations...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38629076/a-novel-flow-cytometry-panel-to-identify-prognostic-markers-for-steroid-sensitive-forms-of-idiopathic-nephrotic-syndrome-in-childhood
#33
JOURNAL ARTICLE
Martina Riganati, Federica Zotta, Annalisa Candino, Ester Conversano, Antonio Gargiulo, Marco Scarsella, Anna Lo Russo, Chiara Bettini, Francesco Emma, Marina Vivarelli, Manuela Colucci
INTRODUCTION: The clinical evolution of steroid-sensitive forms of pediatric idiopathic nephrotic syndrome (INS) is highly heterogeneous following the standard treatment with prednisone. To date, no prognostic marker has been identified to predict the severity of the disease course starting from the first episode. METHODS: In this monocentric prospective cohort study we set up a reproducible and standardized flow cytometry panel using two sample tubes (one for B-cell and one for T-cell subsets) to extensively characterized the lymphocyte repertoire of INS pediatric patients...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628740/uncovering-a-novel-dna-repair-related-radiosensitivity-model-for-evaluation-of-radiotherapy-susceptibility-in-uterine-corpus-endometrial-cancer
#34
JOURNAL ARTICLE
Hainan Yang, Yanru Qiu, Junjun Chen, Jinzhi Lai
BACKGROUND: Uterine corpus endometrial cancer (UCEC) exhibit heterogeneity in their DNA repair capacity, which can impact their response to radiotherapy. Our study aimed to identify potential DNA repair-related biomarkers for predicting radiation response in UCEC. METHODS: We conducted a thorough analysis of 497 UCEC samples obtained from TCGA database. Using LASSO-COX regression analysis, we constructed a radiosensitivity signature and subsequently divided patients into the radiosensitive (RS) and the radioresistant (RR) groups based on their radiosensitivity index...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628708/disulfidptosis-related-lncrna-signature-reveals-immune-microenvironment-and-novel-molecular-subtyping-of-stomach-adenocarcinoma
#35
JOURNAL ARTICLE
Jinze Li, Chuqi Xia, Yilin Song, Lu Zhang, Wei Shang, Ning Xu, Qiyu Lu, Daoming Liang
The main challenge in treating stomach adenocarcinoma (STAD) is chemotherapy resistance, which is characterized by changes in the immune microenvironment. Disulfidptosis, a novel form of programmed cell death, is involved in STAD but its mechanism is not fully understood. Long non-coding RNAs (LncRNAs) may play a role in regulating disulfidptosis and influencing the immune microenvironment and chemotherapy resistance in STAD. This study aims to establish disulfidptosis-related lncRNA (DRL) features and explore their significance in the immune microenvironment and chemotherapy resistance in STAD patients...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628671/human-papillomavirus-circulating-tumor-dna-a-diagnostic-tool-in-squamous-cell-carcinoma-of-unknown-primary-a-pilot-study
#36
JOURNAL ARTICLE
Amani Kais, Stell Patadji Santiago, Peng Cheng Han, David A Clump, William A Stokes, Tanya Fancy, Ruifeng Cui, Elizabeth Martin, Meghan T Turner
INTRODUCTION: Neck mass is the most common presentation of human papillomavirus-related (HPV-related) oropharyngeal squamous cell carcinoma (OPSCC). Recently, circulating tumor HPV-DNA (ctHPVDNA) assays have been developed to detect active OPSCC. This pilot study investigates the diagnostic accuracy of ctHPVDNA in establishing HPV status for known vs. unknown OPSCC presenting as a neck mass. METHODS: A single-institution pilot study was conducted on all patients with OPSCC presenting as a neck mass between 2021 and 2022...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628547/a-lipid-plga-nanocomplex-to-reshape-tumor-immune-microenvironment-for-colon-cancer-therapy
#37
JOURNAL ARTICLE
Nan Zhang, Qiqi Sun, Junhua Li, Jing Li, Lei Tang, Quan Zhao, Yuji Pu, Gaofeng Liang, Bin He, Wenxia Gao, Jianlin Chen
Immune checkpoint blockade therapy provides a new strategy for tumor treatment; however, the insufficient infiltration of cytotoxic T cells and immunosuppression in tumor microenvironment lead to unsatisfied effects. Herein, we reported a lipid/PLGA nanocomplex (RDCM) co-loaded with the photosensitizer Ce6 and the indoleamine 2,3-dioxygenase (IDO) inhibitor 1MT to improve immunotherapy of colon cancer. Arginine-glycine-aspartic acid (RGD) as the targeting moiety was conjugated on 1,2-distearoyl-snglycero-3-phosphoethanolamine lipid via polyethylene glycol (PEG), and programmed cell death-ligand 1 (PD-L1) peptide inhibitor DPPA (sequence: CPLGVRGK-GGG-d(NYSKPTDRQYHF)) was immobilized on the terminal group of PEG via matrix metalloproteinase 2 sensitive peptide linker...
2024: Regenerative Biomaterials
https://read.qxmd.com/read/38627816/ccaat-enhancer-binding-protein-delta-activates-vesicle-associated-membrane-protein-3-transcription-to-enhance-chemoresistance-and-extracellular-pd-l1-expression-in-triple-negative-breast-cancer
#38
JOURNAL ARTICLE
Yan Zhao, Yangyang Yu, Xiangmin Li, Ayao Guo
BACKGROUND: Chemoresistance and immunosuppression are two major obstacles in the current anti-cancer treatments. This study investigates the involvements of a CCAAT enhancer binding protein delta (CEBPD)/vesicle associated membrane protein 3 (VAMP3) axis in paclitaxel (PTX) resistance and immune evasion in triple-negative breast cancer (TNBC). METHODS: PTX resistance-related genes were screened by bioinformatics. CEBPD and VAMP3 expression in clinical TNBC samples was examined by immunohistochemistry...
April 16, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38627815/inhibition-of-autophagy-related-protein-7-enhances-anti-tumor-immune-response-and-improves-efficacy-of-immune-checkpoint-blockade-in-microsatellite-instability-colorectal-cancer
#39
JOURNAL ARTICLE
Wenxin Zhang, Lu Chen, Jiafeng Liu, Bicui Chen, Huanying Shi, Haifei Chen, Huijie Qi, Zimei Wu, Xiang Mao, Xinhai Wang, Yuxin Huang, Jiyifan Li, Zheng Yu, Mingkang Zhong, Tianxiao Wang, Qunyi Li
BACKGROUND: The efficacy of anti-PD-1 therapy is primarily hindered by the limited T-cell immune response rate and immune evasion capacity of tumor cells. Autophagy-related protein 7 (ATG7) plays an important role in autophagy and it has been linked to cancer. However, the role of ATG7 in the effect of immune checkpoint blockade (ICB) treatment on high microsatellite instability (MSI-H)/mismatch repair deficiency (dMMR) CRC is still poorly understood. METHODS: In this study, patients from the cancer genome altas (TCGA) COAD/READ cohorts were used to investigate the biological mechanism driving ATG7 development...
April 16, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38627251/dihydrophenazine-a-multifunctional-new-weapon-that-kills-multidrug-resistant-acinetobacter-baumannii-and-restores-carbapenem-and-oxidative-stress-susceptibilities
#40
JOURNAL ARTICLE
Norhan H Mahdally, Riham A ElShiekh, Bathini Thissera, Ashraf Eltaher, Aya Osama, Maha Mokhtar, Noha M Elhosseiny, Mona T Kashef, Sameh Magdeldin, Ali M El Halawany, Mostafa E Rateb, Ahmed S Attia
AIMS: The current work aims to fully characterize a new antimicrobial agent against Acinetobacter baumannii, which continues to represent a growing threat to healthcare settings worldwide. With minimal treatment options due to the extensive spread of resistance to almost all the available antimicrobials, the hunt for new antimicrobial agents is a high priority. METHODS AND RESULTS: An Egyptian soil-derived bacterium strain NHM-077B proved to be a promising source for a new antimicrobial agent...
April 16, 2024: Journal of Applied Microbiology
keyword
keyword
16363
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.